Testing effectiveness (Phase 2)Ended earlyNCT05047185
What this trial is testing
Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II
Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 34